1. Home
  2. TRDA vs FSBW Comparison

TRDA vs FSBW Comparison

Compare TRDA & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.97

Market Cap

274.5M

Sector

Health Care

ML Signal

HOLD

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$41.28

Market Cap

293.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
FSBW
Founded
2016
1936
Country
United States
United States
Employees
N/A
537
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
274.5M
293.6M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
TRDA
FSBW
Price
$6.97
$41.28
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$21.00
$46.00
AVG Volume (30 Days)
252.6K
10.0K
Earning Date
05-08-2026
04-21-2026
Dividend Yield
N/A
2.79%
EPS Growth
N/A
N/A
EPS
N/A
1.02
Revenue
$25,421,000.00
$4,612,000.00
Revenue This Year
$39.97
$14.94
Revenue Next Year
$50.80
$10.47
P/E Ratio
N/A
$40.50
Revenue Growth
N/A
44.80
52 Week Low
$4.93
$36.72
52 Week High
$16.45
$44.22

Technical Indicators

Market Signals
Indicator
TRDA
FSBW
Relative Strength Index (RSI) 45.70 49.74
Support Level $5.75 $40.79
Resistance Level $7.02 $43.32
Average True Range (ATR) 0.47 0.97
MACD 0.27 -0.03
Stochastic Oscillator 72.36 46.85

Price Performance

Historical Comparison
TRDA
FSBW

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: